For more than 40 years a goal that too often has proved elusive is a pharmaceutical defeat of the human immunodeficiency virus—HIV. And the thrust in recent years has emphasized bringing newer, stealthier weapons to the ...
Research led by the Walter Reed Army Institute of Research, Maryland, has confirmed previous research findings of host restriction factors that target HIV-1. In a paper, "Single-cell transcriptomics identifies prothymosin ...
A large team of researchers affiliated with a host of institutions across the U.S., working with two colleagues from Sweden, reports promising results in a phase I clinical trial aimed at testing the efficacy and safety of ...
A single shot of an experimental injection dramatically reduces levels of the monkey form of HIV in nonhuman primates for at least 30 weeks, according to a study published today in Science. The new research suggests that ...
Aug 8, 2024
0
90
HIV has proven a hard target for vaccine design. The most promising approach, germline-targeting (GT), proposes a series of immunizations: a first shot to activate inexperienced B cells—antibody-producing white blood cells—followed ...
May 21, 2024
0
17
A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.
May 9, 2024
0
12
A study of more than 50 babies in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days—rather than within ...
Dec 5, 2023
0
5
Across Africa about 2 million premature deaths each year are caused by the effects of diabetes and hypertension.
Oct 6, 2023
0
3
Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme ...
Jul 6, 2023
0
20
Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.
Jun 29, 2023
1
15
